US Enforcement Actions Highlight Risks from Online Counterfeit Pharmaceuticals, New Analysis Finds
LISBON – Recent enforcement actions by U.S. authorities are drawing renewed attention to the risks posed by online sales of counterfeit pharmaceuticals, particularly those involving synthetic opioids such as fentanyl, according to a new analysis of publicly available government data and court filings. In February 2026, the U.S. Drug Enforcement Administration (DEA), working with international […]
